Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
4
×
wisconsin blog main
wisconsin top stories
biogen
boston top stories
ipo
accent therapeutics
akouos
alnylam pharmaceuticals
amgen
biomarin pharmaceutical
clinical trials
crispr
deals
What
bio
roundup
covid
ipo
medicines
new
patients
acquisitions
activity
advantages
announced
approvals
bar
becker
billions
biogen
brings
ceo
clamped
collabs
daniel
deal
delays
developing
dollars
drug
eaton
economic
expect
fast
fda
gamble
gene
gilead
gilead’s
healthcare
help
impact
including
introduce
Language
unset
Current search:
cancer
×
" venture capital "
×
" raleigh-durham top stories "
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More